These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7934514)

  • 1. Screening for neuroblastoma.
    Schilling FH; Erttmann R; Ambros PF; Strehl S; Christiansen H; Kovar H; Kabisch H; Treuner J
    Lancet; 1994 Oct; 344(8930):1157-8. PubMed ID: 7934514
    [No Abstract]   [Full Text] [Related]  

  • 2. [Abdominal sympathoma in adults. Apropos of 3 cases, with review of the literature].
    Chevallier B; Testart J; Bastit P
    J Chir (Paris); 1983 Nov; 120(11):623-7. PubMed ID: 6361046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thoracic neuroblastoma].
    Lasson U
    Med Welt; 1980 Feb; 31(7):264-6. PubMed ID: 7366410
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a rapid and reliable method for mass screening for neuroblastoma in infants.
    Schilling FH; Oberrauch W; Schanz F; Treuner J
    Prog Clin Biol Res; 1991; 366():579-83. PubMed ID: 2068176
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of mass screening for neuroblastoma in Sapporo, Japan.
    Takeda T; Nishi M; Shimada M; Nakadate H; Hatae Y; Naito H; Hanai J; Kawai T; Takasugi N
    Prog Clin Biol Res; 1991; 366():595-601. PubMed ID: 2068178
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural course of neuroblastoma detected by mass screening: s 5-year prospective study at a single institution.
    Nishihira H; Toyoda Y; Tanaka Y; Ijiri R; Aida N; Takeuchi M; Ohnuma K; Kigasawa H; Kato K; Nishi T
    J Clin Oncol; 2000 Aug; 18(16):3012-7. PubMed ID: 10944135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The carcinoembryonic antigen assay: Prognostic value in neural crest tumors.
    Frens DB; Bray PF; Wu JT; Lahey ME
    J Pediatr; 1976 Apr; 88(4 Pt 1):591-4. PubMed ID: 1255318
    [No Abstract]   [Full Text] [Related]  

  • 8. Mass screening for neuroblastoma in Miyagi Prefecture.
    Itano M; Morita S; Fujie H; Ohashi Y; Minegishi N; Minegishi M; Yamaguchi Y; Sato T; Tsuchiya S; Konno T
    Tohoku J Exp Med; 1992 Oct; 168(2):137-9. PubMed ID: 1306297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma: an assessment of therapy in reference to staging.
    Koop CE; Johnson DG
    J Pediatr Surg; 1971 Oct; 6(5):595-600. PubMed ID: 5126279
    [No Abstract]   [Full Text] [Related]  

  • 10. The multiple manifestations of neuroblastoma.
    Donohue JP; Garrett RA; Baehner RL; Thomas MH
    Trans Am Assoc Genitourin Surg; 1973; 65():102-7. PubMed ID: 4763503
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for neuroblastoma.
    Craft AW; Dale G
    Lancet; 1987 Nov; 2(8567):1082. PubMed ID: 2889984
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for neuroblastoma in North America--preliminary results from the Quebec project.
    Woods WG; Tuchman M; Lemieux B
    Prog Clin Biol Res; 1991; 366():585-94. PubMed ID: 2068177
    [No Abstract]   [Full Text] [Related]  

  • 13. Pediatric horner syndrome: etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions.
    Rabady DZ; Simon JW; Lopasic N
    Am J Ophthalmol; 2007 Sep; 144(3):481-2; author reply 482. PubMed ID: 17765444
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for neuroblastoma and age-specific incidence.
    Moe PJ
    Acta Paediatr; 1999 Apr; 88(4):362-4. PubMed ID: 10342530
    [No Abstract]   [Full Text] [Related]  

  • 15. Natural history of neuroblastoma found by mass screening.
    Yamamoto K; Hanada R; Tanimura M; Aihara T; Hayashi Y
    Lancet; 1997 Apr; 349(9058):1102. PubMed ID: 9107271
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical evaluation of 23 children with neuroblastoma. The experience of a single institution].
    Piette C; Dresse MF; Forget P; Schmitz V; Demarche M; Erpicum P; Closon MT; Rutten I; Paulus P; Vivegnis D; Beguin Y; Jamblin P; Hoyoux C
    Rev Med Liege; 2005 Mar; 60(3):173-80. PubMed ID: 15884700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Method of measurement of urinary homovanillic acid and vanillylmandelic acid by gas chromatography-mass spectrometry suitable for neuroblastoma screening.
    Seviour JA; McGill AC; Dale G; Craft AW
    J Chromatogr; 1988 Nov; 432():273-7. PubMed ID: 3220894
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for neuroblastoma.
    Norman MG; Dimmick JE; Taylor GP; Teasdale M
    Lancet; 1987 Sep; 2(8558):565-6. PubMed ID: 2887853
    [No Abstract]   [Full Text] [Related]  

  • 19. Mass screening for neuroblastoma in infants.
    Wei M; Ye M; Dong K; Dong R
    Discov Med; 2020; 30(160):63-70. PubMed ID: 33382962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of urinary excretion of vanilmandelic and homovanillic acids in cases of neuroblastoma during therapy].
    Lamedica G; Falcone R; De Bernardi B; Canini S
    Minerva Pediatr; 1978 Jan; 30(2):137-46. PubMed ID: 642879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.